Masterproeven
905 masterproeven gevonden
Targeted long read sequencing to identify missing genetic variation
De Viaene Wannes, Master of science in de Biomedische Wetenschappen, 2024
Promotor: Kim De Leeneer
Layman summary with societal impact The revised criteria for diagnosing patients with NF1 emphasize the importance of genetic variant detection. This research focuses on optimizing current techniques to efficiently and precisely identify variants in potential NF1 patients, which could be a very helpful tool in diagnosis. The ability to detect …
NF1
genetics
Short read sequencing
gDNA
cDNA
Mass Spectrometry Data Cleaning for Improved Identification of Post-Translational Modifications
Marckx Nathan, Master of science in de Biomedische Wetenschappen, 2024
Promotor: Lennart Martens
With this research, the fields of proteomics and bioinformatics could be significantly advanced through improved data pre-processing, leading to enhanced LC-MS data quality. By effectively calibrating proteomics data, this study enables more accurate peptide and protein identification, as well as improved post-translational modification (PTM) analysis. Enhanced PTM identification rates could …
Assessing database construction and reduction methods in metaproteomics
Cattrijsse Wout, Master of science in de Biomedische Wetenschappen, 2024
Promotor: Lennart Martens
This study focuses on rather fundamental research concepts and is therefore further removed from a direct societal impact than translational research. However, this study aims to provide insights into how we can analyse metaproteomic samples with more certainty and accuracy. This is vital if we want to gather truthful and …
Metaproteomics
Mass spectrometry-based proteomics
False discovery rate (FDR)
Target-decoy approach (TDA)
Database construction
Database reduction
Investigating the effects of deubiquitinase-inhibition in hepatocellular carcinoma cell lines
D'Hoore Kathelijne, Master of science in de Biomedische Wetenschappen, 2024
Promotor: Marleen Van Troys
Advanced hepatocellular carcinoma (HCC) remains one of the main causes of cancer death worldwide and was reported by the Surveillance Epidemiology End Results (SEER) as the ‘fastest increasing cause of cancer-related death’. In Belgium, the number of new diagnoses increased from 277 in 2004 to 761 in 2021 (Belgian Cancer …
Investigating the effects of deubiquitinase-inhibition in hepatocellular carcinoma cell lines
lema davina, Master of science in de Biomedische Wetenschappen, 2024
Promotor: Marleen Van Troys
Advanced hepatocellular carcinoma (HCC) remains one of the main causes of cancer death worldwide and was reported by the Surveillance Epidemiology End Results (SEER) as the ‘fastest increasing cause of cancer-related death’. In Belgium, the number of new diagnoses increased from 277 in 2004 to 761 in 2021 (Belgian Cancer …
Non-invasive prenatal screening for the presymptomatic detection of pregnancy complications
Nuwel Caitlin, Master of science in de Biomedische Wetenschappen, 2024
Promotor: Bjorn Menten
Pregnancy complications continue to be a huge burden on prenatal healthcare systems and pregnant women and their fetuses. Today, there is still a lack of accurate screening methods to predict pregnancy complications, such as preeclampsia, early on in pregnancy. Advancements in prenatal screening methods can provide significant benefits to pregnant …
Preeclampsia, cfDNA, DNA methylation analysis, early prediction
Hartvariabiliteit als prognostische waarde van een goed herstel na een acuut myocardinfarct
Diependael Helena, Master of science in de Geneeskunde, 2024
Promotor: Said Hachimi-Idrissi
Via deze masterproef wordt de prognostische waarde van hartritmevariabiliteit (HRV) onderzocht bij mensen die een AMI doorgemaakt hebben. Kan de HRV, berekend op basis van een ECG-ritmestrook van 10 seconden, gebruikt worden om de mortaliteit of morbiditeit na STEMI of NSTEMI te voorspellen? De HRV wordt berekend aan de hand …
mortaliteit
hartritmevariabiliteit
acuut myocardinfarct
STEMI
NSTEMI
complicaties
prognose
DE IMPACT VAN WIJZIGINGEN IN GINA-RICHTLIJNEN OP ASTMA-MANAGEMENT BIJ VOLWASSEN MET MILD TOT MATIG ASTMA GEBASEERD OP REAL LIFE TRIALS
Barbry Giel, Master of science in de Geneeskunde, 2024
Promotor: Guy Brusselle
Beschrijving van de data achter de de wijzigingen in GINA richtlijnen doorheen de jaren voor de behandeling van mild en matig astma.
Mild/matig astma volgens GINA richtlijnen
Conflict or integration of palliative care in phase one trials of patients with cancer. A qualitative study.
De Roeck Roselynn, Master of science in de Geneeskunde, 2024
Promotor: Kim Beernaert
Deze thesis vormt de basis ter uitwerking van een standaardintegratie van palliatieve zorgen tijdens fase I klinisch onderzoek voor patiënten met kanker. Het betreft kwalitatief onderzoek uitgevoerd via semigestructureerd interviews met onderzoekers, oncologen, medewerkers van de dienst palliatieve zorg en patiënten met kanker in fase I studies. Het onderzoek gaat …
palliatieve zorg
fase I klinisch onderzoek
Autologous hematopoietic stem cell transplantation in children with brain tumors: an analysis of the event-free survival and quality of life in long-term survivors.
Speybroeck Céline, Master of science in de Geneeskunde, 2024
Promotor: M. Victoria Bordon Cueto de Braem
Deze retrospectieve studie onderzoekt de effectiviteit en veiligheid van autologe stamceltransplantatie in de behandeling van pediatrische hersentumoren. Dit gebeurt via analyse van de overall survival, event free survival en de kwaliteit van leven in lange termijn overlevers.
Stem cell transplantation
Brain tumors
Long-term consequences
pediatric